Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.14B |
| 2 |
Microsoft
MSFT
|
+$993M |
| 3 |
Alibaba
BABA
|
+$810M |
| 4 |
McDonald's
MCD
|
+$661M |
| 5 |
Home Depot
HD
|
+$425M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 2 |
Chipotle Mexican Grill
CMG
|
+$765M |
| 3 |
Dollar General
DG
|
+$645M |
| 4 |
Apple
AAPL
|
+$450M |
| 5 |
AGN
Allergan plc
AGN
|
+$440M |
Sector Composition
| 1 | Healthcare | 19.03% |
| 2 | Consumer Discretionary | 18.78% |
| 3 | Communication Services | 15.2% |
| 4 | Technology | 12.8% |
| 5 | Financials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
476
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.1M | 0.01% |
312,822
-56,709
| -15% | -$1.83M |
|
|
MNDT
477
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $9.7M | 0.01% |
467,524
-8,474,654
| -95% | -$176M |
|
478
LendingClub
LC
$1.89B
| $9M | 0.01% |
162,874
+6,008
| +4% | +$332K |
|
479
ProQR Therapeutics
PRQR
$245M
| $8.7M | 0.01% |
1,001,774
+33,019
| +3% | +$287K |
|
480
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $8.43M | 0.01% |
367,021
+11,023
| +3% | +$253K |
|
481
Qualys
QLYS
$4.8B
| $8.4M | 0.01% |
253,730
+3,467
| +1% | +$115K |
|
482
Standard BioTools
LAB
$489M
| $8.29M | 0.01% |
767,144
-320,506
| -29% | -$3.46M |
|
483
MacroGenics
MGNX
$109M
| $8.28M | 0.01% |
267,408
+909
| +0.3% | +$28.2K |
|
484
Chord Energy
CHRD
$5.88B
| $8.28M | 0.01% |
1,122,924
-131,134
| -10% | -$966K |
|
|
DMTX
485
DELISTED
Dimension Therapeutics, Inc
DMTX
| $8.27M | 0.01% |
+742,454
| New | +$8.27M |
|
486
SPDR S&P 500 ETF Trust
SPY
$663B
| $8.26M | 0.01% |
+40,494
| New | +$8.26M |
|
487
Salarius Pharmaceuticals
SLRX
$2.36M
| $8.18M | 0.01% |
9
| – | – |
|
|
EPRS
488
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $8.03M | 0.01% |
2,597,868
+3,912
| +0.2% | +$12.1K |
|
489
Semtech
SMTC
$5.34B
| $7.93M | 0.01% |
418,966
-1,238,374
| -75% | -$23.4M |
|
|
DYN.PRA
490
DELISTED
Dynegy Inc.
DYN.PRA
| $7.61M | 0.01% |
150,165
-95,586
| -39% | -$4.84M |
|
491
Brookfield Infrastructure Partners
BIP
$14.2B
| $7.41M | 0.01% |
492,342
+205,737
| +72% | +$3.1M |
|
|
TRVN
492
DELISTED
Trevena, Inc.
TRVN
| $7.38M | 0.01% |
1,124
+4
| +0.4% | +$26.2K |
|
493
Enterprise Products Partners
EPD
$68.3B
| $7.01M | 0.01% |
274,170
+194,913
| +246% | +$4.99M |
|
|
EQM
494
DELISTED
EQM Midstream Partners, LP
EQM
| $7M | 0.01% |
92,797
+54,469
| +142% | +$4.11M |
|
|
CHS
495
DELISTED
Chicos FAS, Inc.
CHS
| $6.92M | 0.01% |
648,719
-114,894
| -15% | -$1.23M |
|
|
ETP
496
DELISTED
Energy Transfer Partners, L.P.
ETP
| $6.65M | 0.01% |
258,583
+128,543
| +99% | +$3.3M |
|
|
AEUA
497
DELISTED
Anadarko Petroleum Corporation
AEUA
| $6.48M | 0.01% |
190,882
+89,182
| +88% | +$3.03M |
|
|
DSCI
498
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $6.43M | 0.01% |
1,407,506
+261,818
| +23% | +$1.2M |
|
499
Ocular Therapeutix
OCUL
$2.22B
| $6.38M | 0.01% |
680,877
-89,355
| -12% | -$837K |
|
500
iShares Russell 1000 Growth ETF
IWF
$119B
| $6.31M | 0.01% |
+63,440
| New | +$6.31M |
|